Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | CD69 | Q07108 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 5/20 | 0.34 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.34 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.31 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.31 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.31 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13994673 | 0.85 | MAPK1 (0.41) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL12213991 | 0.79 | LGALS3 (0.43) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL16016954 | 0.76 | CD69 (0.43) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL13864090 | 0.73 | MAPK1 (0.52) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL22560327 | 0.73 | MAPK1 (0.52) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL23603141 | 0.73 | MAPK1 (0.52) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL21077729 | 0.73 | MAPK1 (0.52) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL24454381 | 0.72 | MAPK1 (0.51) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL20618758 | 0.72 | LGALS3 (0.58) | MAPK1CD69ALDH1A1THRBLGALS3 | |
| SCHEMBL21211570 | 0.72 | CD69 (0.61) | MAPK1CD69ALDH1A1THRBLGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080306023-A1 | Derivatives of Hyaluronic Acid, Their Preparation Process and Their Uses | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306023-A1 | Derivatives of Hyaluronic Acid, Their Preparation Process and Their Uses | CD44, F12, F11 | MAPK1 1602/4885CD69 1600/4885ALDH1A1 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.